A novel RNA‐based adjuvant combines strong immunostimulatory capacities with a favorable safety profile

E-ISSN： 1097-0215|137|2|372-384

ISSN： 0020-7136

Source： INTERNATIONAL JOURNAL OF CANCER, Vol.137, Iss.2, 2015-07, pp. : 372-384

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Model‐based prediction of the acute and long‐term safety profile of naproxen in rats

BRITISH JOURNAL OF PHARMACOLOGY (ELECTRONIC), Vol. 172, Iss. 15, 2015-08 ,pp. : 3861-3874

John Wiley & Sons Inc

Access to resources Recommend Favorite

Propranolol Safety Profile in Children

Current Drug Safety, Vol. 6, Iss. 4, 2011-09 ,pp. : 259-266

Bentham Science Publishers

Access to resources Recommend Favorite

P033: Development of bipolymer based novel nanoparticles in microsphere system as vaccine adjuvant

JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol. 22, Iss. S2, 2015-06 ,pp. : 35-36

John Wiley & Sons Inc

Access to resources Recommend Favorite

Biologic Therapy in Psoriasis: Safety Profile

Current Drug Safety, Vol. 11, Iss. 1, 2016-03 ,pp. : 4-11

Bentham Science Publishers

Access to resources Recommend Favorite

Favorable Toxicity Profile of Raltitrexed in Elderly Patients Treated for Colorectal Cancer: A Case Series

Gerontology, Vol. 49, Iss. 5, 2003-08 ,pp. : 324-327

Karger

Access to resources Recommend Favorite